Published in Hepatitis Weekly, August 18th, 2003
N. Ariki and colleagues, Okayama University, Japan, "investigated the immune responses of patients with cholestatic and HCV positive liver cirrhosis by analyzing T-cell subsets and cytokine levels in the portal and peripheral veins, using flow cytometry and enzyme-linked immunosorbent assay."
They found that "in cholestatic liver cirrhosis, the proportion of natural-killer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.